Grants4Targets program aims to foster new approaches in chemical crop protection / Financial and contentual support for innovative ideas in weed, disease and pest control
Monheim, Germany (February 22, 2016) – Bayer plans to drive forward the scientific debate on new chemical solutions in crop protection. Researchers from universities, other scientific institutions and start-up companies all over the world are therefore being encouraged to take part in Bayer’s new Grants4Targets initiative. The program is aimed at finding innovative approaches in the field of weed, disease and pest control in crop plants.
Bayer will not only provide financial support for promising proposals but also accompany ideas and projects on a scientific basis. During the fostering phase, technologies from Bayer can also be used for further research into promising ideas and projects, which may then develop into regular scientific collaborations.
The objectives include fostering innovative ideas that could contribute to the development of selective and non-selective herbicides, and solutions to control plant disease pathogens (such as fungi) and plant pests (such as insects and nematodes). The focus will lie on new molecular targets and mechanisms of action. Applications for the program can be submitted via a website in a process that takes a few minutes. Only non-confidential information should be submitted; the intellectual property will remain entirely in the hands of the inventors throughout the collaboration.
“The challenges facing agriculture are so great that we need all of the ideas and creativity from small and big companies, universities and other academic institutions alike,” said Dr. Adrian Percy, Head of Research and Development at Crop Science, a Division of Bayer. “We want to talk to scientists from all over the world about their approaches and help to accelerate the transition from fundamental research to products that are ready for the market.”
A similar program for medical applications has been in place at Bayer’s Pharmaceuticals Division since May 2009. Some 1,100 proposals have since been submitted and more than 140 projects supported.
Visit Grants4Targets.Bayer.com/CropScience for all the details about the Crop Science program.
Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.CropScience.Bayer.us.
Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com
Bayer Media Hotline, 1-862-404-5118, or
Crop Science, a Division of Bayer
Tel: (919) 549-5395
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.